New mouse model provides first platform to study late-onset Alzheimer’s disease
Trial of existing antibiotic for treating Staphylococcus aureus bacteremia begins
27 April 2021Researchers identify protein produced after stroke that triggers neurodegeneration
27 April 2021New mouse model provides first platform to study late-onset Alzheimer’s disease
University of California, Irvine biologists have developed a new genetically engineered mouse model, that unlike its predecessors, is based on the most common form of Alzheimer’s disease. The advance holds promise for making new strides against the neurodegenerative disease as cases continue to soar. Their study appears in the journal Nature Communications.
